JBIOJade Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17424
Ticker: JBIO
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2025-04-29
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: JBIO

Detail

Enriched 2026-08-14 20:47

Market cap: $1,476,095,352.27
Shares outstanding (class): 49,359,875
Shares outstanding (weighted): 63,597,387
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 55
Location: WALTHAM, MA
Homepage: https://www.jadebiosciences.com
Description: Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.

Market cap and share counts drift.

Funds holding this security

51 funds · 54 positions · $59.36M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$19.46M	0.00%	1,385,335 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$11.23M	0.02%	799,090 NS	FIGI
abrdn Healthcare Investors —	—	$8.29M	0.73%	589,729 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$5.15M	0.01%	366,818 NS	FIGI
abrdn Life Sciences Investors —	—	$3.90M	0.70%	277,555 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.86M	0.03%	274,725 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.13M	0.09%	80,147 NS	FIGI
VIP Health Care Portfolio Variable Insurance Products Fund IV	—	$843.0K	0.08%	60,000 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$727.7K	0.02%	51,797 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$556.1K	0.03%	39,578 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$473.7K	0.01%	33,715 NS	FIGI
EQ/Small Company Index Portfolio EQ Advisors Trust	—	$354.4K	0.02%	25,227 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$334.8K	0.00%	23,832 NS	FIGI
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$291.6K	0.01%	20,751 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$286.8K	0.00%	20,415 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERJBIO
FIGI_COMPOSITEBBG00WGHZFH4
FIGI_SHARE_CLASSBBG00WGHZFJ2
CIK0001798749
ISINUS0080642061
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a biopharmaceutical company, classified under healthcare pharmaceuticals per SIC 2834.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.